ARTICLE | Clinical News
BMS-663068: Phase IIb data
March 10, 2014 7:00 AM UTC
A double-blind Phase IIb trial in treatment-experienced patients with HIV-1 infection showed that all doses of BMS-663068 as an add-on to raltegravir plus tenofovir met the primary endpoint of respons...